NIH Launches East Palestine Health Research Program
EAST PALESTINE, Ohio, Feb. 3, 2026 — The National Institutes of Health (NIH), part of the U.S. Department of...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
EAST PALESTINE, Ohio, Feb. 3, 2026 — The National Institutes of Health (NIH), part of the U.S. Department of...
TORONTO, Feb. 2, 2026 — American Aires Inc., a technology company focused on transforming electromagnetic field (EMF) environments, announced...
CHICAGO | January 5, 2026 — During National Radon Action Month, the American Lung Association has issued a renewed...
